ScholarIQanswers from OpenAlex & ORCID
Gregor B. E. Jemec
ResearcherPublications, citations & collaboration network
Gregor B. E. Jemec is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Gregor B. E. Jemec have?
ScholarIQindexed works
Gregor B. E. Jemec has 1,007 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Gregor B. E. Jemec have?
ScholarIQcitation count
Gregor B. E. Jemec has 41,325 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Gregor B. E. Jemec?
ScholarIQh-index
Gregor B. E. Jemec has an h-index of 102 in OpenAlex.
What is the i10-index of Gregor B. E. Jemec?
ScholarIQi10-index
Gregor B. E. Jemec has an i10-index of 508 in OpenAlex.
What is the ORCID of Gregor B. E. Jemec?
ScholarIQorcid
The ORCID for Gregor B. E. Jemec is on the source record.
What is the OpenAlex record for Gregor B. E. Jemec?
ScholarIQopenalex
The OpenAlex for Gregor B. E. Jemec is on the source record.
What are the most-cited papers on Gregor B. E. Jemec?
ScholarIQmost cited works
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Alexa B. Kimball, Martin M. Okun, David Williams, Alice B. Gottlieb, Kim Papp, Christos C. Zouboulis, April W. Armstrong, Francisco A. Kerdel, Michael H. Gold, Seth Forman, Neil J. Korman, Evangelos J. Giamarellos‐Bourboulis, Jeffrey Crowley, Charles Lynde, Z. Reguiaï, Errol-Prospero Prens, Eihab Alwawi, Nael M. Mostafa, Brett Pinsky, Murali Sundaram, Yihua Gu, Dawn M. Carlson, Gregor B. E. Jemec
Hidradenitis suppurativa
Robert Sabat, Gregor B. E. Jemec, Łukasz Matusiak, Alexa B. Kimball, Errol P. Prens, Kerstin Wolk
Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity
Christos C. Zouboulis, Thrasyvoulos Tzellos, Αthanassios Kyrgidis, Gregor B. E. Jemec, Falk G. Bechara, Evangelos J. Giamarellos‐Bourboulis, John R Ingram, Theodora Kanni, Ioannis Karagiannidis, Antonio Martorell, Łukasz Matusiak, Andreas Pinter, Errol P. Prens, Dagmar Presser, Sylke Schneider‐Burrus, Esther von Stebut, Jacek C. Szepietowski, Hessel H. van der Zee, Sophia Wilden, Robert Sabat, Rodney Sinclair, Dunja Ana Vekic, P. De Haes, V. del Mármol, Afsáneh Alavi, Wayne Gulliver, Aude Nassif, Georgios Nikolakis, Maurizio Podda, C. Antoniou, Florentina Delli, Clio Dessinioti, Aikaterini Patsatsi, Anastasia Trigoni, C. Zisimou, Vincenzo Bettoli, Simone Garcovich, Jurr Boer, Barbara Horváth, G. Ingvarsson, L. Puig, Robert E. Hunger, Lennart Emtestam, F. William Danby, Alexa B. Kimball
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial
Thomas Ruzicka, Charles Lynde, Gregor B. E. Jemec, Thomas L. Diepgen, J. Berth‐Jones, Pieter‐Jan Coenraads, Andrzej Kaszuba, Robert Bissonnette, E. Varjonen, Péter Holló, F. Cambazard, M. Lahfa, Peter Elsner, Fredrik Nyberg, Åke Svensson, Thomas C. Brown, Martin Harsch, J. Maares
Diagnostic delay in hidradenitis suppurativa is a global problem
Ditte Marie Lindhardt Saunte, Jurr Boer, Alexander Stratigos, Jacek C. Szepietowski, Iltefat Hamzavi, K.H. Kim, Kian Zarchi, C. Antoniou, Łukasz Matusiak, Henry W. Lim, Melissa Williams, Hayoung Kwon, MA Gürer, F. Mammadova, A Kaminsky, Errol P. Prens, Hessel H. van der Zee, Vincenzo Bettoli, Stefania Zauli, Jürg Hafner, Severin Läuchli, Lars E. French, Hassan Riad, Moetaz El‐Domyati, Hossam Abdel‐Wahab, Brian Kirby, G. Kelly, Perla Calderón, V. del Mármol, Farida Benhadou, J. Revuz, Christos C. Zouboulis, Ioannis Karagiannidis, Karin Sartorius, Lena Hagströmer, Erin McMeniman, Nicholas Wei Xun Ong, Mateja Dolenc‐Voljč, Zrinka Bukvić Mokoš, Luca Borradori, Robert E. Hunger, Christopher Sladden, Noah Scheinfeld, Nayera Moftah, Lennart Emtestam, Jan Lapins, N. Doss, Ichiro Kurokawa, Gregor B. E. Jemec